Amwell® Announces Results for Fourth Quarter and Full Year 2025

Rhea-AI Summary

Amwell (NYSE: AMWL) announced fourth-quarter and full-year 2025 financial results and will host a conference call today, Feb 12, 2026, at 5:00 p.m. ET.

The company said investors can view the earnings release and access a live audio webcast at the provided link; a replay will be available for ~90 days on the investor site.

Key Figures

Reporting period end: December 31, 2025 Conference call time: 5 p.m. ET Webcast replay window: 90 days +2 more

5 metrics

Reporting period end December 31, 2025 Fourth quarter and full year 2025 results

Conference call time 5 p.m. ET Earnings call on Feb. 12, 2026

Webcast replay window 90 days Replay availability on investors.amwell.com

Fourth quarter year 2025 Quarterly results being reported

Full year reported 2025 Annual financial results

Market Reality Check

Price: $4.42 Vol: Volume 92,767 is 1.15x th...

normal vol

$4.42 Last Close

Volume Volume 92,767 is 1.15x the 20-day average of 80,878 ahead of earnings. normal

Technical Shares trade below the 200-day MA at 6.13, with price at 4.32.

Peers on Argus

AMWL is down 2.04% with several health information peers also lower: CCLD -5.49%...

1 Up

AMWL is down 2.04% with several health information peers also lower: CCLD -5.49%, FORA -0.72%, HCAT -4.78%, SOPH -5.53%, MNDR -2.37%, indicating broader sector softness.

Previous Earnings Reports

5 past events · Latest: Nov 04 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 04	Q3 2025 earnings	Neutral	-0.8%	Reported Q3 2025 results and held standard earnings call and webcast.
Aug 05	Q2 2025 earnings	Neutral	-7.3%	Announced Q2 2025 results with scheduled earnings call and webcast replay.
May 01	Q1 2025 earnings	Neutral	+19.7%	Released Q1 2025 financials and hosted a 5 p.m. ET conference call.
Feb 12	FY/Q4 2024 earnings	Neutral	-5.0%	Reported Q4 and full-year 2024 financial results with accompanying webcast.
Oct 30	Q3 2024 earnings	Neutral	-5.1%	Posted Q3 2024 financial results and held same-day earnings call.

Pattern Detected

Earnings releases have produced mixed but generally modest moves, averaging about 0.3% over the last five comparable announcements.

Recent Company History

Over the last five earnings releases from Oct 2024 through Nov 2025, Amwell has consistently announced quarterly or annual results with an investor call and webcast. Price reactions ranged from about -7.31% to +19.71%, with an average move of 0.3%, showing variable but often contained responses. This new fourth quarter and full year 2025 release continues that cadence of regular financial updates and conference calls.

Historical Comparison

earnings

+0.3 %

Average Historical Move

Historical Analysis

In the past five earnings releases, AMWL moved an average of 0.3% on the day. Today’s pre-announcement move of -2.04% came against that backdrop of typically modest earnings-day reactions.

Typical Pattern

Earnings updates have tracked Amwell from Q3 2024 through Q1–Q3 2025 and FY/Q4 2024, leading into today’s FY/Q4 2025 report and maintaining a regular quarterly disclosure pattern.

Market Pulse Summary

This announcement continues Amwell’s pattern of regular quarterly and annual earnings updates, with ...

Analysis

This announcement continues Amwell’s pattern of regular quarterly and annual earnings updates, with FY and Q4 2025 results accompanied by a 5 p.m. ET conference call and 90-day webcast replay. Historically, earnings have triggered varied but often modest price moves, averaging about 0.3%. Investors following this cadence typically watch for changes in the company’s trajectory across successive quarters and any commentary on strategic priorities.

Key Terms

saas-based, webcast

2 terms

saas-based technical

"a comprehensive SaaS-based software platform for technology-enabled healthcare"

Software-as-a-service (SaaS)-based describes products delivered over the internet where the provider hosts and maintains the software and customers pay ongoing subscription fees instead of buying a one-time license. For investors this matters because the business model tends to produce predictable, recurring revenue and growth that depends on keeping customers over time, much like renting a furnished apartment provides steady income for a landlord rather than a single large sale.

webcast technical

"The call can be accessed via a live audio webcast at https://edge.media-server.com"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

AI-generated analysis. Not financial advice.

BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell^® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company’s fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com.

Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/7o2zjx2o/. A webcast replay will be available for approximately 90 days at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
press@amwell.com

Investors:
Asher Dewhurst
amwell@icrhealthcare.com

FAQ

When is Amwell (AMWL) discussing its Q4 and full-year 2025 results?

Amwell will hold a conference call on Feb 12, 2026 at 5:00 p.m. ET. According to the company, the live audio webcast link is provided for real-time access and a replay will be posted for about 90 days on the investor site.

Where can I find Amwell (AMWL) Q4 and full-year 2025 earnings release?

The earnings report is available at the company investor website investors.amwell.com. According to Amwell, the full fourth-quarter and full-year 2025 earnings materials can be viewed and downloaded from that investor relations page.

How can investors listen to Amwell's (AMWL) Feb 12, 2026 earnings webcast?

Investors can join the live audio webcast via the provided media-server URL at the scheduled time. According to the company, the same webcast will have a replay available for roughly 90 days on the investor relations site.

Will Amwell (AMWL) provide a replay of the Feb 12, 2026 earnings call?

Yes, a webcast replay will be available for approximately 90 days after the call. According to Amwell, investors can access the replay via investors.amwell.com following the live audio presentation.

Does Amwell (AMWL) disclose financial figures in the Feb 12, 2026 announcement?

The announcement states that fourth-quarter and full-year 2025 results were released but does not include specific financial figures in the notice. According to the company, detailed metrics are available in the full earnings release on the investor site.